{
  "id": 9153185,
  "title": "Cost blocks public access to RSV protection for babies",
  "url": "https://urgent.news/2026/09/22/cost-blocks-public-access-to-rsv-protection-for-babies",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T14:49:46.000Z",
  "source": {
    "name": "Mail and Guardian",
    "slug": "mail-and-guardian",
    "url": "https://mg.co.za/news/south-africa/2026-09-22-cost-blocks-public-access-to-rsv-protection-for-babies/"
  },
  "original_language": "en",
  "account": null,
  "summary": "High costs are preventing newly approved maternal vaccines and antibody treatments for RSV from entering South Africa's public healthcare system, leaving vulnerable infants without protection.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}